There’s been a lot of talk about the surge in the College’s popularity but, as a bit of a thought experiment, I pose the question - is the University (overall) actually weaker across the board now than in the recent past? Some evidence that indicates the answer could be yes (organized by school division):
UChicago Medicine/Hospital System
The biggest decline seems to be here. Rankings are of course a rough barometer, but the results here are stark. In 2003, UChicago Hospitals ranked #14 overall, in the ballpark of Michigan, Stanford, U. of Penn, etc., and well ahead of Northwestern (which was unranked). In 2003, UChicago Hospitals was generally considered the preeminent hospital system in the Chicago-land area.
Now, in 2016, UChicago hospitals is unranked, and Northwestern Memorial is #8. They have almost flipped spots.
(Sources: http://www.webmd.com/a-to-z-guides/news/20030718/2003-us-best-hospital-rankings#1 and http://www.webmd.com/a-to-z-guides/news/20030718/2003-us-best-hospital-rankings#1)
Perhaps more worryingly, for a long time, cancer research/treatment was a big part of Chicago’s portfolio. In 2000, Chicago was SIXTH (#6) in the country for this specialty. In 2015, they had dropped to 34th.
This is a really big drop. Rumor is Northwestern has poached some of Chicago’s top researchers/docs, and Chicago has simply lost ground. Instead of being the frontrunner in Chicago, they’ve been pulled back considerably.
(The medical school’s ranking is still strong, but this is because - in a disappointing move, the school decided to REDUCE the number of medical students in its classes, despite the general notion of a doctor shortage.)
The success of a medical plant is now crucial to any major research university. Medical plants bring in big dollars, connect a school with a community, etc. The optics of the trauma center fight for Chicago hasn’t been good, either.
The hospital system has a lot of ground to make up - not just nationally, but in the city of Chicago.
The Law School
Like many schools, Chicago saw their LSAT averages decline, but, for the first time in a little while, there’s a gap in scoring between Columbia Law and Chicago Law. Columbia’s median LSAT is 172, Chicago’s is now 170, despite Chicago have a drastically smaller incoming class size. (Sources: Columbia and Chicago’s Entering Class Profile/FAQ pages.) Chicago’s median used to be 172.
Chicago’s production of Supreme Court clerks, a big brass ring in law, and sometimes a rough barometer of a school’s station, has fallen precipitously in recent years. From 1991 to 2005, Chicago produced a whopping 65 clerks (about 4-5 a year). From 2006 to 2016, Chicago produced 18 a year (1-2 a year). (Sources: http://www.leiterrankings.com/jobs/1991scotus_clerks.shtml and http://www.law.uchicago.edu/students/careerservices/clerkships.
(It’s US News ranking has held relatively steady at #4, but the gap between Chicago and it’s generally closest competitor, Columbia, seems to have widened.)
Chicago Booth Business School
Rankings-wise, the school is placing well, but it lost a tremendous dean, Edward Snyder, to Yale, and Snyder’s follow-up, Sunil Kumar, is leaving for Johns Hopkins. Also, as the B-school climate shifts more toward tech/entrepreneurship, Chicago is very much playing catch-up here. It’s always been strong in quant finance, but it is struggling to build the ecosystem found elsewhere (see: Stanford, Wharton’s burgeoning climate for tech/ent and the Pennovation center, the new Harvard innovation lab, etc.)
NIH Funding and Fundraising
Money is the lifeblood of any significant research institution. Chicago’s fundraising efforts, relative to its peers, has been flagging, and NIH funding is actually going down.
Re NIH funding - in 2006, Chicago’s medical school received $170M in funding (ranked #21 in the nation, not bad for a plant of its size). This was well above Northwestern, which received about $125M in funding. In 2016, the tables have turned significantly, NU now receives $220M in funding (18th in the nation), and Chicago’s funding actually went DOWN to $155M (down to #28 in the nation).
NIH funding usually links to the number of “big deal” faculty lab leaders (called Principal Investigators, or PIs) a university has. Prominent PIs can bring in a lot of NIH funding, which usually leads to publication of “big deal” research papers, which usually leads to higher (or sustained) levels of NIH funding. A decrease in NIH funding can signify a brain drain on the science end of campus.
(Sources: for 2006, see “Total NIH awards” data found here: http://www.brimr.org/NIH_Awards/2006/NIH_Awards_2006.htm and for 2015, see here: http://www.brimr.org/NIH_Awards/2015/NIH_Awards_2015.htm)
Similarly, in terms of fundraising, Chicago is in the midst of a $4.5B fundraising campaign. That sounds like a lot, doesn’t it? Well, it’s progressing slowly, especially when compared to other peers, AND it’s smaller than other campaigns. Harvard will raise about $8B (it’s already surpassed it’s $6.5B goal), Johns Hopkins recently increased their goal to $5B given momentum, and Northwestern’s $3.75B campaign looks to surpass their goal too. Chicago’s campaign looks to take a long time, and is flagging a bit.
Other Considerations
Of course, the University has made strides - student life is better, Hyde Park is better, new collaborations have emerged (with the Marine Biological Institute, Institute of Politics, etc.), and old ones have been maintained (e.g. Argonne). The points I raise above, however, are worrying - especially the trends for the medical plant and revenue streams.
Thoughts?